Article ID Journal Published Year Pages File Type
5698334 Clinical Oncology 2017 8 Pages PDF
Abstract
HPA dysfunction in patients treated for non-pituitary intracranial neoplasms is probably a result of both neurosurgery and radiotherapy treatments. Although statistically significant endocrine changes can occur during this first year of follow-up, those documented at year 1 may be more predictive of subsequent HPA dysfunction.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , , ,